VA
VR Adviser Portfolio holdings
AUM
$1.33B
This Quarter Return
-12.6%
1 Year Return
+6.92%
3 Year Return
+862.77%
5 Year Return
+1,580.48%
10 Year Return
–
AUM
$508M
AUM Growth
+$508M
(-18%)
Cap. Flow
+$35.9M
Cap. Flow
% of AUM
7.07%
Top 10 Holdings %
Top 10 Hldgs %
74.09%
Holding
34
New
7
Increased
6
Reduced
5
Closed
7
Top Buys
| 1 |
Cogent Biosciences
COGT
|
$26.6M |
| 2 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
$25.5M |
| 3 |
INZY
Inozyme Pharma
INZY
|
$12.9M |
| 4 |
AKUS
Akouos, Inc. Common Stock
AKUS
|
$12.5M |
| 5 |
GH Research
GHRS
|
$11.3M |
Top Sells
| 1 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
$13.9M |
| 2 |
Athira Pharma
ATHA
|
$13.5M |
| 3 |
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
|
$12.2M |
| 4 |
Nuvalent
NUVL
|
$11.2M |
| 5 |
LENZ
LENZ Therapeutics
LENZ
|
$8.22M |
Sector Composition
| 1 | Healthcare | 96.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Rallybio
RLYB
$22.4M
| $2.03M | 0.4% | +268,532 | New | +$2.03M |
|
27
Xenon Pharmaceuticals
XENE
$2.98B
| $913K | 0.18% | +30,000 | New | +$913K |
|
|
28
Athira Pharma
ATHA
$15.3M
| – | – | -1,000,000 | Closed | -$13.5M |
|
29
Astria Therapeutics
ATXS
$349M
| – | – | -538,999 | Closed | -$3.62M |
|
|
CNTA
30
Centessa Pharmaceuticals
CNTA
$2.25B
| – | – | -411,361 | Closed | -$3.69M |
|
|
31
Nuvalent
NUVL
$5.52B
| – | – | -803,951 | Closed | -$11.2M |
|
|
LENZ
32
LENZ Therapeutics
LENZ
$1.1B
| – | – | -1,612,617 | Closed | -$8.22M |
|
|
EIGR
33
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| – | – | -1,469,767 | Closed | -$12.2M |
|
|
SRRA
34
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| – | – | -162,479 | Closed | -$5.21M |
|